Results 301 to 310 of about 357,544 (339)

Research progress on the source, production, and anti-cancer mechanisms of paclitaxel.

Chinese Journal of Natural Medicines, 2020
Paclitaxel, a tetracyclic diterpenoid compounds, was firstly isolated from the bark of the Pacific yew trees. Currently, as a low toxicity, high efficiency, and broad-spectrum natural anti-cancer drug, paclitaxel has been widely used against ovarian ...
Yanhua Yang, Jiawang Mao, Xiaoli Tan
semanticscholar   +1 more source

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.

The Lancet Gastroenterology and Hepatology, 2020
BACKGROUND The optimal preoperative treatment for locally advanced pancreatic cancer is unknown. We aimed to compare the efficacy and safety of nab-paclitaxel plus gemcitabine with nab-paclitaxel plus gemcitabine followed by fluorouracil, leucovorin ...
V. Kunzmann, J. Siveke, H. Algül, E. Goekkurt, G. Siegler, U. Martens, D. Waldschmidt, U. Pelzer, M. Fuchs, F. Kullmann, S. Boeck, T. Ettrich, S. Held, R. Keller, I. Klein, C. Germer, H. Stein, H. Friess, M. Bahra, R. Jakobs, I. Hartlapp, V. Heinemann   +21 more
semanticscholar   +1 more source

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.

Journal of Clinical Oncology, 2018
Purpose Intraperitoneal paclitaxel plus systemic chemotherapy demonstrated promising clinical effects in patients with gastric cancer with peritoneal metastasis.
H. Ishigami, Y. Fujiwara, R. Fukushima, A. Nashimoto, H. Yabusaki, M. Imano, H. Imamoto, Y. Kodera, Y. Uenosono, K. Amagai, S. Kadowaki, H. Miwa, H. Yamaguchi, Takuhiro Yamaguchi, T. Miyaji, J. Kitayama   +15 more
semanticscholar   +1 more source

Paclitaxel

Reactions Weekly, 2015
  +6 more sources

Mechanisms of cancer cell death induction by paclitaxel: an updated review

Apoptosis, 2022
Shuxiang Zhao, Yufei Tang, Ruohan Wang, M. Najafi   +3 more
semanticscholar   +1 more source

Paclitaxel

Reactions Weekly, 2007
  +4 more sources

Paclitaxel (Taxol)

New England Journal of Medicine, 1995
E K, Rowinsky, R C, Donehower
openaire   +2 more sources

Paclitaxel

Reactions Weekly
  +7 more sources

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

New England Journal of Medicine, 2019
H. O’sullivan, D. Collins, S. O'Reilly
semanticscholar   +1 more source

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

The Lancet Oncology, 2014
H. Wilke, K. Muro, E. Van Cutsem, S. Oh, G. Bodoky, Y. Shimada, S. Hironaka, N. Sugimoto, O. Lipatov, Tae-You Kim, D. Cunningham, P. Rougier, Y. Komatsu, J. Ajani, M. Emig, R. Carlesi, D. Ferry, K. Chandrawansa, J. Schwartz, A. Ohtsu   +19 more
semanticscholar   +1 more source